I. Tzoulaki

First name

I.

Last name

Tzoulaki

Zheng, B., Su, B., Ahmadi-Abhari, S., Kapogiannis, D., Tzoulaki, I., Riboli, E., & Middleton, L. (2023). Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment. Alzheimers Dement. http://doi.org/10.1002/alz.13349

View

Huang, J., Su, B., Karhunen, V., Gill, D., Zuber, V., Ahola-Olli, A., et al. (2022). Inflammatory Diseases, Inflammatory Biomarkers, and Alzheimer Disease: An Observational Analysis and Mendelian Randomization. Neurology. http://doi.org/10.1212/wnl.0000000000201489

View

Zheng, B., Su, B., Udeh-Momoh, C., Price, G., Tzoulaki, I., Vamos, E. P., et al. (2022). Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study. J Prev Alzheimers Dis, 9, 86-91. http://doi.org/10.14283/jpad.2022.8

View

Tzoulaki, I., Molokhia, M., Curcin, V., Little, M. P., Millett, C. J., Ng, A., et al. (2009). Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. Bmj. http://doi.org/10.1136/bmj.b4731

View

Tsilidis, K. K., Capothanassi, D., Allen, N. E., Rizos, E. C., Lopez, D. S., van Veldhoven, K., et al. (2014). Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial. Diabetes Care. http://doi.org/10.2337/dc14-0584

View

Zheng, B., Su, B., Price, G., Tzoulaki, I., Ahmadi-Abhari, S., & Middleton, L. (2021). Glycemic Control, Diabetic Complications, and Risk of Dementia in Patients With Diabetes: Results From a Large U.K. Cohort Study. Diabetes Care. http://doi.org/10.2337/dc20-2850

View